Literature DB >> 23122044

Penile imaging.

Anuradha Shenoy-Bhangle1, Rocio Perez-Johnston, Ajay Singh.   

Abstract

In Peyronie disease, magnetic resonance (MR) imaging is better than ultrasound in detecting impalpable plaques and plaque dimensions, whereas calcified plaques are better visualized on ultrasound. Ultrasound with color Doppler technique is superior to MR imaging in evaluating vascular causes of erectile dysfunction. In penile fractures, MR imaging should be performed with the patient in the erect position to avoid kinking between the pendulous and fixed parts and thus enable better demonstration of the site of tunica albuginea disruption for surgical planning. MR imaging is better than ultrasound in delineating primary penile malignancies and demonstrating lymph nodal involvement. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23122044     DOI: 10.1016/j.rcl.2012.08.009

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

Review 1.  Peyronie's disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up.

Authors:  Sultan Al-Thakafi; Naif Al-Hathal
Journal:  Transl Androl Urol       Date:  2016-06

2.  The Effect of Testosterone Replacement Therapy on Penile Hemodynamics in Hypogonadal Men With Erectile Dysfunction, Having Veno-Occlusive Dysfunction.

Authors:  Ozan Efesoy; Selahittin Çayan; Erdem Akbay
Journal:  Am J Mens Health       Date:  2018-03-26

3.  A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.

Authors:  L Toscano; M V Rezende; L F Mello; D Paulillo; S Glina
Journal:  Int Braz J Urol       Date:  2016 Sep-Oct       Impact factor: 1.541

4.  Penile fracture: role of ultrasound.

Authors:  Nishant Gupta; Pradeep Goyal; Komal Sharma; Itisha Bansal; Sonali Gupta; Shuo Li; Kenneth Zinn; Yogesh Kumar
Journal:  Transl Androl Urol       Date:  2017-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.